These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23221385)

  • 1. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
    Mertens JC; Fingas CD; Christensen JD; Smoot RL; Bronk SF; Werneburg NW; Gustafson MP; Dietz AB; Roberts LR; Sirica AE; Gores GJ
    Cancer Res; 2013 Jan; 73(2):897-907. PubMed ID: 23221385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.
    Ilyas SI; Mertens JC; Bronk SF; Hirsova P; Dai H; Roberts LR; Kaufmann SH; Gores GJ
    J Biol Chem; 2014 Aug; 289(33):22835-22849. PubMed ID: 24973208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
    Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
    Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
    Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
    Cells; 2024 May; 13(10):. PubMed ID: 38786020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
    Zhang Z; Lai GH; Sirica AE
    Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
    Korelin K; Oostveen M; Wahbi W; Ianevski F; Cavalcante B; Turunen L; Belevich I; Al-Samadi A; Salo T
    Biomed Pharmacother; 2024 Jun; 175():116719. PubMed ID: 38749173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts.
    Chen B; Wang Z; Sun J; Song Q; He B; Zhang H; Wang X; Dai W; Zhang Q
    Nanomedicine; 2016 Jan; 12(1):131-41. PubMed ID: 26518604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1.
    Li G; Zhang S; Fang H; Yan B; Zhao Y; Feng L; Ma X; Ye X
    Biochem Biophys Res Commun; 2013 May; 434(4):809-14. PubMed ID: 23611778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
    Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax.
    Sitia L; Bonizzi A; Mazzucchelli S; Negri S; Sottani C; Grignani E; Rizzuto MA; Prosperi D; Sorrentino L; Morasso C; Allevi R; Sevieri M; Silva F; Truffi M; Corsi F
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
    Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
    Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
    Romani AA; Desenzani S; Morganti MM; Baroni MC; Borghetti AF; Soliani P
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):557-67. PubMed ID: 20473610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer.
    Potter DS; Du R; Bhola P; Bueno R; Letai A
    Cell Death Dis; 2021 Jul; 12(8):741. PubMed ID: 34315868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells.
    Smoot RL; Blechacz BR; Werneburg NW; Bronk SF; Sinicrope FA; Sirica AE; Gores GJ
    Cancer Res; 2010 Mar; 70(5):1960-9. PubMed ID: 20160031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.
    Fingas CD; Blechacz BR; Smoot RL; Guicciardi ME; Mott J; Bronk SF; Werneburg NW; Sirica AE; Gores GJ
    Hepatology; 2010 Aug; 52(2):550-61. PubMed ID: 20683954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.